Nuvisan

Nuvisan is a full-service contract research organization (CRO) and contract development and manufacturing organization (CDMO) founded over 40 years ago by pharmaceutical industry experts. The company operates state-of-the-art laboratories in Germany and France, serving pharmaceutical and biotechnology companies, venture capital firms, and nonprofit organizations.

Capabilities

Nuvisan provides end-to-end solutions spanning drug discovery and development through market launch. Key service areas include:

• Analytical Services: Method development, validation, quality control, stability studies, EU re-testing, and commercial release for small and large molecules
• Clinical Services: Phase 1–2 clinical development, biostatistics, and clinical development consulting
• Drug Discovery & Development: Target molecule identification through therapeutic commercialization

Competency Centers

The organization operates specialized centers:

• Berlin: Drug discovery research
• Sophia Antipolis, France: Formulation development and GMP manufacturing
• Neu-Ulm, Germany: Bioanalytical services (founded 1979)

Approach

Nuvisan emphasizes flexibility, transparency, and collaborative partnership to meet individual client requirements, minimize risk, and ensure project success. The company positions itself as a scientific partner committed to solving complex therapeutic development challenges.